Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYSZ2100524	门冬胰岛素50注射液	Insulin aspart protamine recombinant;insulin aspart recombinant	Injection	Biological Products	License Renew	2021-07-21					view
JYSZ2100523	门冬胰岛素50注射液	Insulin aspart protamine recombinant;insulin aspart recombinant	Injection	Biological Products	License Renew	2021-07-21					view
JYSZ2000017	门冬胰岛素注射液	insulin aspart	Injection	Biological Products	License Renew	2020-11-23	丹麦诺和诺德公司	Novo Nordisk A/S	In Review	2020-11-21	view
JYSZ2000016	门冬胰岛素注射液	insulin aspart	Injection	Biological Products	License Renew	2020-11-23	丹麦诺和诺德公司	Novo Nordisk A/S	In Review	2020-11-21	view
JYSZ1900010	门冬胰岛素注射液	insulin aspart	Injection	Biological Products	License Renew	2019-03-04	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2019-11-25	view
JYSZ1900009	门冬胰岛素注射液	insulin aspart	Injection	Biological Products	License Renew	2019-03-08	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2019-11-25	view
JYSZ1900008	门冬胰岛素注射液	insulin aspart	Injection	Biological Products	License Renew	2019-03-08	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2019-11-25	view
JYSZ1800053	门冬胰岛素30注射液	Insulin aspart protamine recombinant;insulin aspart recombinant	Injection	Biological Products	License Renew	2018-09-30	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2019-08-15	view
JYSZ1800052	门冬胰岛素30注射液	Insulin aspart protamine recombinant;insulin aspart recombinant	Injection	Biological Products	License Renew	2018-10-11	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2019-08-15	view
JYSZ1800051	门冬胰岛素30注射液	Insulin aspart protamine recombinant;insulin aspart recombinant	Injection	Biological Products	License Renew	2018-10-11	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2019-08-15	view
JYSF2000025	门冬胰岛素注射液	insulin aspart	Injection	Biological Products(3.1)	Supplementary Application	2020-10-16	丹麦诺和诺德公司	Novo Nordisk A/S	Filed	2020-10-30	view
JYSF1900022	门冬胰岛素注射液	insulin aspart	Injection	Biological Products	Supplementary Application	2019-12-16	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2019-12-30	view
JYSF1900009	门冬胰岛素30注射液	Insulin aspart protamine recombinant;insulin aspart recombinant	Injection	Biological Products	Supplementary Application	2019-08-24	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2019-09-19	view
JYSB2200033	门冬胰岛素50注射液	Insulin aspart protamine recombinant;insulin aspart recombinant	Injection	Biological Products	Supplementary Application	2022-02-28		Novo Nordisk A/S			view
JYSB2200032	门冬胰岛素50注射液	Insulin aspart protamine recombinant;insulin aspart recombinant	Injection	Biological Products	Supplementary Application	2022-02-28		Novo Nordisk A/S			view
JYSB2200003	门冬胰岛素30注射液	Insulin aspart protamine recombinant;insulin aspart recombinant	Injection	Biological Products	Supplementary Application	2022-01-06		Novo Nordisk A/S			view
JYSB2200002	门冬胰岛素30注射液	Insulin aspart protamine recombinant;insulin aspart recombinant	Injection	Biological Products	Supplementary Application	2022-01-06		Novo Nordisk A/S			view
JYSB2101211	门冬胰岛素注射液	insulin aspart	Injection	Biological Products	Supplementary Application	2021-12-23		Novo Nordisk A/S			view
JYSB2101210	门冬胰岛素注射液	insulin aspart	Injection	Biological Products	Supplementary Application	2021-12-23		Novo Nordisk A/S			view
JYSB2101209	门冬胰岛素注射液	insulin aspart	Injection	Biological Products	Supplementary Application	2021-12-23		Novo Nordisk A/S			view